"The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous. @drharshvardhanshould please clarify. Its use should be avoided till full trials are over. India can start with the AstraZeneca vaccine in the meantime," Tharoor tweeted.
https://ift.tt/3nab2S3
0 Comments